Raquel Guiomar , Beatriz Catoira , Paula Castilho , Chris Baeken , Ana Ganho-Ávila
{"title":"Optimisation and development of new tDCS montages to target the cerebellum in schizophrenia: An electrical current modeling study","authors":"Raquel Guiomar , Beatriz Catoira , Paula Castilho , Chris Baeken , Ana Ganho-Ávila","doi":"10.1016/j.schres.2025.06.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Schizophrenia is a severe psychiatric disorder that affects individuals' cognitive, social, and emotional functioning. Negative symptoms, such as reduced motivation and social withdrawal, are refractory to available treatments and often contribute to poor functioning and quality of life. The cerebellum has been implicated in the pathophysiology of schizophrenia and is a potential target for treatment with non-invasive brain stimulation, for example transcranial direct current stimulation (tDCS). Previous studies have used conventional and high-definition (HD) tDCS montages to target the cerebellum, but these methods have limitations in terms of intensity and focality. Therefore, there is a need to test new cerebellar tDCS montages that optimize both the intensity and focality of the induced electric field.</div><div>Objective: To test two new tDCS montages (PO10Chin and VermisChin) targeting the right posterior cerebellum and vermis and compare their effectiveness with three commonly used cerebellar tDCS montages.</div></div><div><h3>Methods</h3><div>Electric field simulations for five tDCS montages were compared using linear mixed-effects models (LMMs) to assess current intensity and focality in clinical and healthy groups.</div></div><div><h3>Results</h3><div>The PO10Chin montage showed the highest electric current intensity over the right posterior cerebellum, while VermisChin demonstrated high intensity and focality over the vermis. The HD montage exhibited strong intensity but poor focality, with current hotspots mainly in the occipital cortex. Although the healthy control group was associated with higher current intensity, the effect size was small and therefore can be considered negligible, suggesting that the new montages show similar results for both clinical and non-clinical samples.</div></div><div><h3>Conclusion</h3><div>The PO10Chin and VermisChin montages demonstrated highest intensity for right posterior and vermal cerebellum, respectively, compared with the other montages making them promising approaches for targeting the cerebellum in future in vivo studies. Future research should explore the underlying mechanisms, consider safety measures, and evaluate the clinical efficacy of these new montages.</div></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":"283 ","pages":"Pages 48-58"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0920996425002336","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Schizophrenia is a severe psychiatric disorder that affects individuals' cognitive, social, and emotional functioning. Negative symptoms, such as reduced motivation and social withdrawal, are refractory to available treatments and often contribute to poor functioning and quality of life. The cerebellum has been implicated in the pathophysiology of schizophrenia and is a potential target for treatment with non-invasive brain stimulation, for example transcranial direct current stimulation (tDCS). Previous studies have used conventional and high-definition (HD) tDCS montages to target the cerebellum, but these methods have limitations in terms of intensity and focality. Therefore, there is a need to test new cerebellar tDCS montages that optimize both the intensity and focality of the induced electric field.
Objective: To test two new tDCS montages (PO10Chin and VermisChin) targeting the right posterior cerebellum and vermis and compare their effectiveness with three commonly used cerebellar tDCS montages.
Methods
Electric field simulations for five tDCS montages were compared using linear mixed-effects models (LMMs) to assess current intensity and focality in clinical and healthy groups.
Results
The PO10Chin montage showed the highest electric current intensity over the right posterior cerebellum, while VermisChin demonstrated high intensity and focality over the vermis. The HD montage exhibited strong intensity but poor focality, with current hotspots mainly in the occipital cortex. Although the healthy control group was associated with higher current intensity, the effect size was small and therefore can be considered negligible, suggesting that the new montages show similar results for both clinical and non-clinical samples.
Conclusion
The PO10Chin and VermisChin montages demonstrated highest intensity for right posterior and vermal cerebellum, respectively, compared with the other montages making them promising approaches for targeting the cerebellum in future in vivo studies. Future research should explore the underlying mechanisms, consider safety measures, and evaluate the clinical efficacy of these new montages.
期刊介绍:
As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!
Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.
The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.